Guided Therapeutics

(OTC) GTHP

Current Price$0.18

Market Cap$17.38M

Since IPO (1997)-100%

5 Year-77%

1 Year+44%

1 Month-10%

Guided Therapeutics Financials at a Glance

Market Cap

$17.38M

Revenue (TTM)

$767.00K

Net Income (TTM)

$3.93M

EPS (TTM)

$-0.05

P/E Ratio

-3.89

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.18

Volume

11,401

Open

$0.18

Price

$0.18

Volume

11,401

Open

$0.18

Previous Close

$0.18

Daily Range

$0.18 - $0.18

52-Week Range

$0.09 - $0.54

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.18

Volume

11,401

Open

$0.18

Previous Close

$0.18

Daily Range

$0.18 - $0.18

52-Week Range

$0.09 - $0.54

GTHP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Guided Therapeutics

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Mark L. Faupel, PhD

Website

www.guidedinc.com

Headquarters

Norcross, GA 30092, US

GTHP Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

-3%

Net Income Margin

-5%

Return on Equity

Return on Capital

57%

Return on Assets

-2%

Earnings Yield

-25.71%

Dividend Yield

0.00%

Payout Ratio

-2.06%

Stock Overview

Market Cap

$17.38M

Shares Outstanding

96.54M

Volume

11.40K

Avg. Volume

17.18K

Financials (TTM)

Gross Profit

$571.00K

Operating Income

$2.37M

EBITDA

$2.47M

Operating Cash Flow

$1.07M

Capital Expenditure

$2.00K

Free Cash Flow

$1.07M

Cash & ST Invst.

$63.00K

Total Debt

$2.94M

Guided Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$24.00K

+4.0%

Gross Margin

0.00%

N/A

Market Cap

$17.38M

N/A

Market Cap/Employee

$4.34M

N/A

Employees

N/A

Net Income

$1.01M

-137.2%

EBITDA

$495.00K

-94.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$2.24M

-18.2%

Accounts Receivable

$4.00K

+100.0%

Inventory

$469.00K

-25.9%

Long Term Debt

$818.00K

+605.2%

Short Term Debt

$2.02M

+5.7%

Return on Assets

-2.45%

N/A

Return on Invested Capital

56.84%

N/A

Free Cash Flow

$617.00K

-86.4%

Operating Cash Flow

$617.00K

-86.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VPTDFVentriPoint Diagnostics Ltd.

VPTDFVentriPoint Diagnostics Ltd.$0.10-7.76%

UEECUnited Health Products, Inc.

UEECUnited Health Products, Inc.$0.06+1.82%

ASAPFAurora Spine Corporation

ASAPFAurora Spine Corporation$0.18+2.86%

EMITFElbit Imaging Ltd.

EMITFElbit Imaging Ltd.$1.60+0.00%

ZHCLFZenith Capital Corp.

ZHCLFZenith Capital Corp.$0.05+0.00%

PYNKFPerimeter Medical Imaging AI, Inc.

PYNKFPerimeter Medical Imaging AI, Inc.$0.26+17.15%

IMMVFImmunovia AB (publ)

IMMVFImmunovia AB (publ)$0.02+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

Questions About GTHP

What is the current price of Guided Therapeutics?

Guided Therapeutics is trading at $0.18 per share.

What is the 52-week range for Guided Therapeutics?

Over the past 52 weeks, Guided Therapeutics has traded between $0.09 and $0.54.

How much debt does Guided Therapeutics have?

As of the most recent reporting period, Guided Therapeutics reported total debt of $2.79M.

How much cash does Guided Therapeutics have on hand?

Guided Therapeutics reported $369,000 in cash and cash equivalents in its most recent financial results.

What is Guided Therapeutics’s dividend yield?

Guided Therapeutics does not currently have a dividend yield.

Guided Therapeutics

Guided Therapeutics Financials at a Glance

GTHP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Guided Therapeutics

GTHP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Guided Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GTHP

What is the current price of Guided Therapeutics?

What is the 52-week range for Guided Therapeutics?

How much debt does Guided Therapeutics have?

How much cash does Guided Therapeutics have on hand?

What is Guided Therapeutics’s dividend yield?

Premium Investing Services